Table 1 Characteristics of patients and place of death
Diagnosis1 | Diagnosed (01/09/04-31/08/10) | Deceased (by 31/08/12) | Place of death | ||||
|---|---|---|---|---|---|---|---|
N | Median age at diagnosis | N (% of those diagnosed) | Hospital | Home | Nursing home | Hospice | |
N (% of deaths) | N (% of deaths) | N (% of deaths) | N (% of deaths) | ||||
Total | 10325 | 70.9 | 4829 (46.8) | 3183 (65.9) | 753 (15.6) | 532 (11.0) | 361 (7.5) |
Myeloma | 1399 | 73.0 | 887 (63.4) | 572 (64.5) | 139 (15.7) | 107 (12.0) | 69 (7.8) |
Diffuse large B-cell lymphoma | 1604 | 70.4 | 831 (51.8) | 535 (64.5) | 122 (14.7) | 94 (11.3) | 80 (9.6) |
Myelodysplastic syndromes | 794 | 76.0 | 595 (74.9) | 422 (70.9) | 94 (15.8) | 44 (7.4) | 35 (5.9) |
Acute myeloid leukaemia | 722 | 71.1 | 573 (79.4) | 413 (72.1) | 81 (14.1) | 41 (7.2) | 38 (6.6) |
Chronic lymphocytic leukaemia | 1279 | 71.6 | 424 (33.2) | 276 (65.1) | 74 (17.5) | 50 (11.8) | 24 (5.6) |
Myeloproliferative neoplasms | 1187 | 71.2 | 283 (23.8) | 161 (56.9) | 50 (17.7) | 53 (18.7) | 19 (6.7) |
Marginal zone lymphoma | 625 | 72.2 | 229 (36.6) | 141 (61.6) | 28 (12.2) | 42 (18.3) | 18 (7.9) |
Lymphoproliferative disorder NOS2 | 378 | 77.0 | 165 (43.7) | 101 (61.2) | 26 (15.8) | 30 (18.2) | 8 (4.8) |
Follicular lymphoma | 656 | 64.5 | 148 (22.6) | 91 (61.5) | 29 (19.6) | 16 (10.8) | 12 (8.1) |
Hodgkin lymphoma | 576 | 44.4 | 126 (21.9) | 94 (74.6) | 17 (13.5) | 10 (7.9) | 5 (4.0) |
Mantle cell lymphoma | 173 | 74.0 | 123 (71.1) | 66 (53.7) | 24 (19.5) | 13 (10.6) | 20 (16.2) |
T-cell lymphoma | 206 | 64.9 | 117 (56.8) | 83 (70.9) | 20 (17.1) | 5 (4.3) | 9 (7.7) |
Chronic myelomonocytic leukaemia | 127 | 77.4 | 89 (70.1) | 64 (71.9) | 16 (18.0) | 7 (7.9) | 2 (2.2) |
Acute lymphoblastic leukaemia | 112 | 47.5 | 77 (68.8) | 53 (68.8) | 10 (13.0) | 4 (5.2) | 10 (13.0) |
Primary myelofibrosis | 88 | 74.1 | 49 (55.7) | 34 (69.4) | 8 (16.3) | 3 (6.1) | 4 (8.2) |
Chronic myeloid leukaemia | 203 | 59.2 | 44 (21.7) | 32 (72.7) | 4 (9.1) | 5 (11.4) | 3 (6.8) |
Burkitt lymphoma | 53 | 57.6 | 30 (56.6) | 21 (70.0) | 5 (16.6) | 2 (6.7) | 2 (6.7) |
T-cell leukaemia | 80 | 74.7 | 30 (37.5) | 19 (63.3) | 4 (13.3) | 5 (16.7) | 2 (6.7) |
Hairy cell leukaemia | 63 | 65.5 | 9 (14.3) | 5 (55.6) | 2 (22.2) | 1 (11.1) | 1 (11.1) |